VEA
XBIT icon

Virtus ETF Advisers’s XBiotech XBIT Stock Holding History

Virtus ETF Advisers’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,424
Closed -$187K – 398
2021
Q3 		$187K Buy
14,424
+1,078
+8% +$17.2K 0.08% 284
2021
Q2 		$221K Sell
13,346
-2,526
-16% -$42.8K 0.09% 271
2021
Q1 		$273K Buy
15,872
+288
+2% +$5.38K 0.12% 265
2020
Q4 		$244K Sell
15,584
-7,592
-33% -$140K 0.1% 320
2020
Q3 		$442K Sell
23,176
-3,164
-12% -$54.6K 0.23% 150
2020
Q2 		$361K Buy
26,340
+8,245
+46% +$116K 0.17% 251
2020
Q1 		$192K Sell
18,095
-2,640
-13% -$43K 0.08% 278
2019
Q4 		$387K Buy
+20,735
New +$267K 0.06% 271

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtus ETF Advisers's XBIT Position: Q4 2021 in Review

Virtus ETF Advisers sold out of XBiotech (XBIT) in Q4 2021, closing a stake of 14,424 shares — an estimated $187K sold.

Virtus ETF Advisers first reported a position in XBIT in Q4 2019 and held it in 8 quarters. The position peaked at $442K in Q3 2020. 61 funds tracked by Wall St. Rank hold XBIT as of Q4 2021.

  • Virtus ETF Advisers reported no remaining XBiotech position as of Q4 2021 after selling out during the quarter.
  • Virtus ETF Advisers sold 14,424 XBiotech shares in Q4 2021, an estimated $187K.
  • Virtus ETF Advisers first reported a position in XBiotech in Q4 2019 and held it in 8 quarters.
  • Virtus ETF Advisers's XBiotech position peaked at $442K in Q3 2020.
  • 61 funds tracked by Wall St. Rank held XBiotech as of Q4 2021.

Based on Virtus ETF Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.